The professor and has team received the prestigious Misha Mahowald Prize in Neuromorphic Engineering for their work on ...
First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation of trial sites underway for ground-breaking Phase 3 pivo ...
McCollough and Hernandez stepped down from Proenza Schouler in January but remain on its board. The brand is currently led by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results